Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors

Haemostasis

Volumn 28, Issue 2, 1999, Pages 93-98

  Arkin, S ^a   Cooper, H A ^b   Hutter, J J ^c   Miller, S ^d   Schmidt, M L ^e   Seibel, N L ^f   Shapiro, A ^g   Warrier, I ^h  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d Children's Medical Center of Brooklyn   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^f CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^g INDIANA UNIVERSITY   (United States)

^h CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Activated recombinant human coagulation factor VII; Hemophilia; Inhibitors; Intracranial hemorrhage

Indexed keywords

BLOOD CLOTTING FACTOR 7; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BRAIN HEMORRHAGE; BRAIN SCINTISCANNING; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; CEREBRAL HEMORRHAGE; CHILD, PRESCHOOL; FACTOR VIIA; HEMOPHILIA A; HEMOPHILIA B; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; MALE; RECOMBINANT PROTEINS;

EID: 0032461210     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Eyster ME, Gill FM, Blatt PM, Hilgartner MW, Ballard JO, Kinney TR, the Hemophilia Study Group: Central nervous system bleeding in hemophiliacs. Blood 1978;51:1179-1188.
2. Bray GL, Luban NL: Hemophilia presenting with intracranial hemorrhage. Am J Dis Child 1987;141:1215-1220.
3. Yoffe G, Buchanan GR: Intracranial hemorrhage in newborn and young infants with hemophilia. J Pediatr 1988;113:333-336.
4. Martinowitz U, Heim M, Tadmor R, Eldor A, Rider I, Findler G, Sahar A, Ramot B: Intracranial hemorrhage in patients with hemophilia. Neurosurgery 1986;18:538-541.
5. Lusher JM: Management of hemophiliacs with inhibitors; in Hilgartner MW, Pochedly C (eds): Hemophilia in the Child and Adult, ed 3. New York, Raven Press, 1989.
6. Hedner U, Glazer S: Management of hemophilia patients with inhibitors. Hematol Oncol Clin North Am 1992;6:1035.
7. Ingerslev J, Freidman D, Gastineau D, Gilchrist G, Johnsson H, Lucas G, McPherson J, Preston E, Scheibel E, Shuman M: Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa. Haemostasis 1996;26(suppl 1):118-123.
8. Schmidt ML, Gamerman S, Smith HE, Scott JP, DiMichele DM: Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors. Am J Hematol 1994;47:36-40.
9. Hedner U: Experiences with recombinant factor VIIa in haemophiliacs. Curr Stud Hematol Blood Transfus 1991;58:63-68.
10. Maliekel K, Rana N, Green D: Recombinant factor VIIa in the management of a pseudotumor in acquired hemophilia. Haemophilia 1997;3:54-58.
11. Doughty HA, Northeast A, Sklair L, Roques T, Young AE, Savidge GF, Hunt BJ: The use of recombinant factor VIIa in a patient with acquired hemophilia A undergoing surgery. Blood Coagul Fibrinolysis 1995;6:125-128.
12. Macik BG, Lindley CM, Lusher J, Sawyer WT, Bloom AL, Harrison JF, Baird-Cox K, Birch K, Glazer S, Roberts HR: Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): Results of a phase I study. Blood Coagul Fibrinolysis 1993;4:521-527.
13. Majumdar G, Phillips JK, Lavallee H, Savidge GF: Recombinant factor VIIa for intracranial hemorrhage in a Jehovah's Witness with severe hemophilia A and factor VIII inhibitors. Blood Coagul Fibrinolysis 1993;4:1031-1033.